Trending...
- Sacramento resident and author, Susan D. Powers, puts family first in her new book - 189
- TVS Boxing Network Adds Six Greatest Fights of the 20th Century to Summer Schedule on WatchYour.TV
- TVS Vintage Network.Com Adds Iconic Family Shows From First Decade of Television, on WatchYour.TV
SAN DIEGO - Californer -- From Athos, Porthos, and Aramis to Luke, Leia, and Han, something magical happens when three forces unite.
Today, a trio of cutting-edge companies announced a global collaboration that will enable nearly instant medical test results, bypassing traditional biological laboratories and forwarding critical data to doctors, hospitals and health agencies.
"From COVID-19 to leukemia, patients and clinicians need fast and accurate diagnoses," said Lonnie Adelman, CEO of San Diego's iAssay. "This collaboration will revolutionize how scientific and medical data is produced, collected, and shared."
The techniques pioneered by these three companies – iAssay of San Diego, Calif.; GattaCo of Murrieta, Calif.; and Taiwan's Helios Bioelectronics – can be used by engineers as well as medical professionals. Besides medical and scientific applications, soil or water samples,could be tested for toxins, minerals or other materials.
More on The Californer
"By using many strands," said Dr. Hardy Chan, CEO of Helios, "we are weaving a stronger rope."
Helios Bioelectronics is the developer of a multi-patented electrochemical chip, the FET Chip, which identifies targeted elements such as viral proteins or nucleic acids that can be used to identify diseases such as COVID-19. Sometimes called "lab on a chip," this nanotechnology enables a vast amount of information to be gathered through assays processed at the point-of-care that would otherwise rely on detection via laboratories.
Using its patented sample purification technology, GattaCo has developed a plasma separation tool, the A-PON™. The A-PON automatically separates plasma from whole blood collected from a finger-stick without needing a centrifuge. GattaCo is developing a blood analysis cartridge system that integrates its sample purification technology together with Helios Bioelectronics' FET Chip. This cartridge will be read by iAssay's SimpleTest™ base technology with an adaptor specifically developed for the Helios/GattaCo cartridge.
More on The Californer
iAssay's patented SimpleTest™ automatically interprets test and control indications on a variety of medical tests. After SimpleTest™ produces a test result, the device transmits the results to the company's SimpleCloud™, where results can be viewed in a password protected portal by doctors, hospitals, state and federal agencies, or scientists for research.
"This partnership has the potential of saving time, yes, but also saving lives," said Dr. Michael McNeely, president of GattaCo. "Knowledge is power, and the sooner patients and their doctors understand what they are dealing with, the sooner they can seek the correct treatment."
"Health and safety are universal needs," said Helios' Chan. "We may be on the other side of the world from our California partners, but we stand shoulder-to-shoulder with them in this essential work."
Visit http://www.iassay.net for details.
Visit http://www.gattaco.com for details.
Visit heliosbioelectronics.com for details.
Today, a trio of cutting-edge companies announced a global collaboration that will enable nearly instant medical test results, bypassing traditional biological laboratories and forwarding critical data to doctors, hospitals and health agencies.
"From COVID-19 to leukemia, patients and clinicians need fast and accurate diagnoses," said Lonnie Adelman, CEO of San Diego's iAssay. "This collaboration will revolutionize how scientific and medical data is produced, collected, and shared."
The techniques pioneered by these three companies – iAssay of San Diego, Calif.; GattaCo of Murrieta, Calif.; and Taiwan's Helios Bioelectronics – can be used by engineers as well as medical professionals. Besides medical and scientific applications, soil or water samples,could be tested for toxins, minerals or other materials.
More on The Californer
- Mark Goode to Build Alliant Public Entity Education & Pooling Practice
- The South Florida International Film Festival Awards Event for June 2021 Celebrated Filmmakers and Screenwriters
- California: Governor Newsom Meets with New FEMA Administrator on Devastation of Climate Crisis, Signs Resources Budget Trailer Bill
- What are the methods to ring at Google
- Amobee Names Nick Brien as Chief Executive Officer
"By using many strands," said Dr. Hardy Chan, CEO of Helios, "we are weaving a stronger rope."
Helios Bioelectronics is the developer of a multi-patented electrochemical chip, the FET Chip, which identifies targeted elements such as viral proteins or nucleic acids that can be used to identify diseases such as COVID-19. Sometimes called "lab on a chip," this nanotechnology enables a vast amount of information to be gathered through assays processed at the point-of-care that would otherwise rely on detection via laboratories.
Using its patented sample purification technology, GattaCo has developed a plasma separation tool, the A-PON™. The A-PON automatically separates plasma from whole blood collected from a finger-stick without needing a centrifuge. GattaCo is developing a blood analysis cartridge system that integrates its sample purification technology together with Helios Bioelectronics' FET Chip. This cartridge will be read by iAssay's SimpleTest™ base technology with an adaptor specifically developed for the Helios/GattaCo cartridge.
More on The Californer
- California: Newsom Administration Secures 12 Additional Firefighting Aircraft to Support Statewide Fire Response
- Outdoor Access for All: California Establishes New Pilot Programs to Expand Youth Access to State Parks
- TVS Flashback Network.Com Adds Diffren't Strokes, Golden Girls, and Becker to Fall Schedule
- Extreme Tech Challenge Announces Strategic Partnership With the Food & Agriculture Organization of the United Nations to Advance Technology-Enabled Resilient Food Systems
- Sho Richardsin Release New Music The Dude (Shogi)
iAssay's patented SimpleTest™ automatically interprets test and control indications on a variety of medical tests. After SimpleTest™ produces a test result, the device transmits the results to the company's SimpleCloud™, where results can be viewed in a password protected portal by doctors, hospitals, state and federal agencies, or scientists for research.
"This partnership has the potential of saving time, yes, but also saving lives," said Dr. Michael McNeely, president of GattaCo. "Knowledge is power, and the sooner patients and their doctors understand what they are dealing with, the sooner they can seek the correct treatment."
"Health and safety are universal needs," said Helios' Chan. "We may be on the other side of the world from our California partners, but we stand shoulder-to-shoulder with them in this essential work."
Visit http://www.iassay.net for details.
Visit http://www.gattaco.com for details.
Visit heliosbioelectronics.com for details.
Source: iAssay, inc.
Filed Under: Biotech
0 Comments
Latest on The Californer
- GA-ASI and UK MoD Exercise Contract for Additional 13 Protector RPAS
- KIMTRUE Shares Secrets to Getting and Maintaining Beautiful, Healthy Hair
- JetMax AI Vision Robotic Arm to be launched soon on Kickstarter
- Sonorous Records To Release 8 Albums Of Original Recordings By The Five Blind Boys Of Alabama
- Storage Made Easy announces SMBStream™, a new product that offers secure accelerated access to SMB Shares over the Internet
- Things to know before change or cancellation of your booked flight
- Twilio Achieves Full Compliance with STIR/SHAKEN Protocols to Combat Illegal Robocalls
- Gymboree Play & Music Announces Collaboration with DreamWorks Animation Series, Gabby's Dollhouse
- (CVA Alert) Johnson Fistel Investigates Proposed Sale of Covanta; Is $20.25 a Fair Price?
- NeoPhotonics to Host Conference Call to Discuss 2021 Second Quarter Financial Results on Tuesday, August 3, 2021
- Angel brings a delightful song with a powerful message called; You will always be (My Baby Girl)
- Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe USA - English USA - English
- California: Governor Newsom Statement on Proposed $26 Billion National Opioid Settlement
- Diversity News Media Brands Publisher Files Trademark For Diversity News Magazine Dot Com Domain Name
- Glancy Prongay & Murray LLP Obtains Important Ruling for Tenaris S.A. Investors in Securities Fraud Class Action
- CLARA Analytics Appoints Tom Warden as Chief Insurance and Science Officer
- Governor, Mayors and Police Chiefs Talk Public Safety in Long Beach
- Markethive Standing Tall In The New Ocean Of Crypto Currencies
- California: Governor Newsom Signs Legislation to Bolster State's Film and Television Industry, Creating Good Jobs and Promoting a Diverse Workforce
- California: Governor Newsom Joins Law Enforcement Leaders and Big 13 Mayors to Discuss State Efforts to Reduce Crime, Signs Legislation Targeting Organized Retail Theft